Farther Finance Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145K | Sell |
661
-103
| -13% | -$22.5K | ﹤0.01% | 1558 |
|
|
2025
Q1 | $168K | Sell |
764
-214
| -22% | -$47.1K | ﹤0.01% | 1295 |
|
|
2024
Q4 | $320K | Buy |
978
+54
| +6% | +$17.7K | 0.01% | 780 |
|
|
2024
Q3 | $278K | Sell |
924
-635
| -41% | -$191K | 0.01% | 861 |
|
|
2024
Q2 | $506K | Buy |
1,559
+1,163
| +294% | +$377K | 0.02% | 478 |
|
|
2024
Q1 | $157K | Buy |
396
+90
| +29% | +$35.6K | 0.01% | 777 |
|
|
2023
Q4 | $108K | Buy |
306
+71
| +30% | +$25K | 0.01% | 779 |
|
|
2023
Q3 | $88.2K | Buy |
235
+8
| +4% | +$3K | 0.01% | 604 |
|
|
2023
Q2 | $86.8K | Buy |
227
+50
| +28% | +$19.1K | 0.02% | 504 |
|
|
2023
Q1 | $61.3K | Sell |
177
-18
| -9% | -$6.24K | 0.02% | 547 |
|
|
2022
Q4 | $45.9K | Buy |
+195
| New | +$45.9K | 0.02% | 511 |
|